This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024

John Schardt, Ph.D.
Senior Scientist at AstraZeneca


John S. Schardt earned his BSc from Lehigh University in 2013, and his PhD from the University of Maryland in 2018 as a joint fellow with the National Cancer Institute. He conducted postdoctoral research at the University of Michigan as an NIH F32 fellow. John joined AstraZeneca in the Biologics Engineering group in 2022, focusing on the development of next-generation T cell engager modalities. Overall, his research applies molecular discovery and engineering approaches to develop novel therapeutic strategies for immuno-oncology, infectious disease, and more.

Agenda Sessions

  • Design Meets Biology – Engineering Immune Engagers with Potentially Improved Therapeutic Index


At this event